Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity

被引:23
|
作者
de Vries, Paul S. [1 ]
Boender, Johan [2 ]
Sonneveld, Michelle A. H. [2 ,3 ]
Rivadeneira, Fernando [1 ,4 ]
Ikram, M. Arfan [1 ,3 ,5 ]
Rottensteiner, Hanspeter [6 ]
Hofman, Albert [1 ]
Uitterlinden, Andre G. [1 ,4 ]
Leebeek, Frank W. G. [2 ]
Franco, Oscar H. [1 ]
Dehghan, Abbas [1 ]
de Maat, Moniek P. M. [2 ]
机构
[1] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[2] Erasmus MC, Dept Hematol, Rotterdam, Netherlands
[3] Erasmus MC, Dept Neurol, Rotterdam, Netherlands
[4] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[5] Erasmus MC, Dept Radiol, Rotterdam, Netherlands
[6] Baxter Innovat GmbH, Vienna, Austria
关键词
VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; FACTOR-CLEAVING PROTEASE; ABO BLOOD-GROUP; SACCHAROMYCES-CEREVISIAE; MYOCARDIAL-INFARCTION; MISSENSE MUTATION; LOW-FREQUENCY; TRANSCRIPTION; GENOME;
D O I
10.1182/blood-2015-02-629865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A disintegrin and metalloproteinase with thrombospondin motifs 13(ADAMTS13) cleaves von Willebrand factor, reducing its prothrombotic activity. The genetic determinants of ADAMTS13 activity remain unclear. We performed a genome-wide association study of ADAMTS13 activity in the Rotterdam Study, a population-based cohort study. We used imputed genotypes of common variants in a discovery sample of 3443 individuals and replication sample of 2025 individuals. We examined rare exonic variant associations in ADAMTS13 in 1609 individuals using an exome array. rs41314453 in ADAMTS13 was associated with ADAMTS13 activity in both our discovery (beta, -20.2%; P=1.3 x 10(-33)) and replication sample (P = 3.3 x 10(-34)), and explained 3.6% to 6.5% of the variance. In the combined analysis of our discovery and replication samples, there were 2 further independent associations at the ADAMTS13 locus: rs3118667 (beta, 3.0; P = 9.6 x 10(-21)) and rs139911703 (beta, -11.6; P=3.6 x 10(-8)). In addition, rs10456544 in SUPT3H was associated with a 4.2 increase in ADAMTS13 activity (P = 1.13.6 x 10(-8)). Finally, we found 3 independent associations with rare coding variants in ADAMTS13: rs148312697 (beta, -32.2%; P = 3.7 x 10(-6)), rs142572218 (beta, -46.0%; P = 3.9 x 10(-5)), and rs36222275 (beta, -13.9%; P = 2.9 x 10(-3)). In conclusion, we identified rs41314453 as the main genetic determinant of ADAMTS13 activity, and we present preliminary findings for further associations at the ADAMTS13 and SUPT3H loci.
引用
收藏
页码:3949 / 3955
页数:7
相关论文
共 50 条
  • [21] SNPs in ADAMTS13
    Tseng, Sandra Chang
    Kimchi-Sarfaty, Chava
    PHARMACOGENOMICS, 2011, 12 (08) : 1147 - 1160
  • [22] Measurement of ADAMTS13 activity and inhibitors
    Miyata, T
    Kokame, K
    Banno, F
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (05) : 384 - 389
  • [23] Evaluation of an ADAMTS13 activity ELISA
    Butler, J.
    Butler, J. J.
    Malan, E.
    Clifford, J.
    Wheeler, M.
    Gan, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 563 - 563
  • [24] Significant fraction of ADAMTS13 activity is associated with activated platelets and their micropartictes (PMP): Implication for regulating ADAMTS13 activity.
    Jy, Wenche
    Lin, Andrew
    Bidot, Loreta
    Bang, Jaehoon
    Ahn, Eugene
    Horstman, Lawrence L.
    Jimenez, Joaquin J.
    Bidot, Carlos J.
    Ahn, Yeon-Soong
    BLOOD, 2006, 108 (11) : 317A - 318A
  • [25] GWA study for ADAMTS13 activity
    Miyata, Toshiyuki
    BLOOD, 2015, 125 (25) : 3833 - 3834
  • [26] The Highs and Lows of ADAMTS13 Activity
    Shaw, Rebecca J.
    Abrams, Simon T.
    Badu, Samuel
    Toh, Cheng-Hock
    Dutt, Tina
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [27] ADAMTS13 ACTIVITY IN ACUTE TTP
    AlShemmari, Mariam
    AlDallal, Nasser
    EXPERIMENTAL HEMATOLOGY, 2018, 64 : S54 - S54
  • [28] Hypochlorous acid inactivates ADAMTS13: an oxidative mechanism for regulating ADAMTS13 activity during inflammation
    Fu, X.
    Wang, Y.
    Chen, J.
    Ling, M.
    Kulman, J. D.
    Lopez, J. A.
    Chung, D. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 964 - 964
  • [29] ADAMTS13 antigen, activity, and autoantibody and ADAMTS13/fXI complex levels in patients with venous thromboembolism
    Fryer, Hugh J. L.
    Grafos, Nicholas
    Gbinto, Enriqueta R.
    Wu, Jogin
    Bing, Bai
    Greenfield, Robert S.
    BLOOD, 2007, 110 (11) : 487A - 488A
  • [30] Heterozygous ADAMTS13 mutations in idiopathic TTP with severe acquired ADAMTS13 deficiency
    Meyer, S. C.
    Jin, S.
    Cao, W.
    Pos, W.
    Voorberg, J.
    Zheng, X. L.
    Laemmle, B.
    Hovinga, Kremer J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 960 - 960